We report a fatal case of pulmonary tuberculosis masquerading as diffuse alveolar hemorrhage after autologous stem cell transplant.
Mycobacterial infection is uncommon during bone marrow transplantation. Review of BMT patients at large US centers revealed an incidence rate of 0.49-1%. [1] [2] [3] Most of the cases are caused by Mycobacterium avium complex in the US. Mycobacterium tuberculosis infection associated with bone marrow transplantation is very rare. We report a fatal case of Mycobacterium tuberculosis masquerading as diffuse alveolar hemorrhage (DAH) after autologous stem cell transplant.
Case report
A 25-year-old Hispanic male was diagnosed with diffuse large B cell lymphoma, stage IIB with bulky mediastinal disease, in September 1996. He was treated initially with cyclophosphamide, doxorubicin, vincristine and prednisone for seven cycles. Because of persistent mediastinal disease, chemotherapy was switched to cisplatin, high-dose cytarabine and dexamethasone, and mediastinal radiation of 4200 cGy was also given. Nevertheless, his disease progressed and he was then treated with mitoxantrone, paclitaxel, ifosfamide and mesna with a partial response. Peripheral blood stem cells mobilized by G-CSF were collected. On admission for transplantation, the patient was afebrile. He has no personal or family history of tuberculosis. He received total body irradiation of 150 cGy twice daily from days −8 to −5, high-dose etoposide 60 mg/kg on day −4, cyclophosphamide 100 mg/kg on day −2, followed by reinfusion of autologous stem cells with total mononuclear He developed a temperature of 38.3°C on day −3 and was started on imipenem/cilastatin. His absolute neutrophil count (ANC) decreased to zero on day 1. He continued to have high temperatures of up to 39.4°C every day despite switching and adding various antibiotics, including vancomycin ceftazidium, gentamicin and amphotericin B. On day 10, bilateral infiltrates in the upper and mid lungs were noted (Figure 1 ). Sulphamethaxazole/trimethoprim and erythromycin were added to treat possible pneumocystic carinii (PCP) and atypical pneumonia. The patient did not have hemoptysis. He achieved myeloid engraftment with ANC greater than 500/l by day 11. On day 12, fiberoptic bronchoscopy was performed and revealed erythematous mucosa and fresh blood coming from the left upper and lingula lobes, as well as dry blood in the right lower lobe. The lingula lobe was lavaged using normal saline with uniformly bloody return. Bronchial washings were negative for legionella, chlamydia, mycoplasma, PCP, respiratory syncytial virus, adenovirus, herpes simplex and cytomegalovirus. Acid fast bacilli staining was negative. With a tentative diagnosis of diffuse alveolar hemorrhage, intravenous methylprednisolone of 200 mg was started and followed by 100 mg given daily. His respiratory status and chest radiograph continued to deteriorate and he required mechanical ventilation by day 13. Bronchoscopy was repeated after intubation and it revealed no additional findings. He succumbed 2 weeks later. Request for autopsy was not granted. Approximately 10 days after his death, Mycobacterium tuberculosis was recovered from the culture of bronchial washings.
Discussion
Diffuse alveolar hemorhage is well described in the autologous bone marrow transplant setting. [4] [5] [6] [7] It is more commonly seen in older patients, patients with lymphoma, prior mediastinal radiation and those where total body irradiation was included as part of the conditioning regimen. 4, 6 It usually presents with dyspnea, nonproductive cough, fever of up to 39.4°C and bilateral pulmonary infiltrates about 11-12 days after transplant. 4, 6, 7 The treatment of choice is corticosteroid which has significantly improved survival from 9% to 33%. 5, 6 With the diagnosis of lymphoma, the prior history of mediastinal radiation and TBI, our patient had the typical setting for developing DAH. However, the presumptive diagnosis was incorrect.
Mycobacterial infection is more common in patients with cell-mediated immunodeficiency. However, very few cases have been reported associated with bone marrow transplantation. [1] [2] [3] [8] [9] [10] Most of the reported cases are either from areas such as Hong Kong and Spain where the infection is prevalent, related to allogeneic transplant or associated with graft-versus-host disease. Mycobacterial infection after autologous transplant is very rare with only two cases having been reported 2,10 presumably due to the fact that autotransplantation is less immunosuppressive than allogeneic transplantation.
In retrospect, the lack of significant response after corticosteroid and the initially predominant involvement in the upper lobes should have raised the possibility of pulmonary tuberculosis. A high index of suspicion is important in making this diagnosis, and prompt and appropriate treatment will invariably improve the outcome of this disease.
